Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit

Infection Control and Hospital Epidemiology

Volumn 29, Issue 11, 2008, Pages 1066-1070

  Atif, Mohamed Lamine ^a,b   Sadaoui, Fetta ^a   Bezzaoucha, Abdeldjallil ^a   Kaddache, Chawki Ahmed ^a   Boukari, Rachida ^a   Djelato, Salima ^a   Boubechou, Nora ^a  

^a Centre Hospitalo universitaire de Blida   (Algeria)

^b CHU Mustapha   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL FINANCE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; NEWBORN; NEWBORN CARE; PHARMACY; PRESCRIPTION;

ALGERIA; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITAL COSTS; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES;

EID: 54949095477     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/591858     Document Type: Article

References (21)

1. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110 (2 pt 1):285-291.
2. Leroyer A, Bedu A, Lombrail P, et al. Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. J Hosp Infect 1997; 35:37-45.
3. Girard R, Fabry J, Meynet R, Lambert DC, Sepetjan M. Costs of nosocomial infection in a neonatal unit. J Hosp Infect 1983; 4:361-366.
4. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 2001; 47:223-229.
5. Van Der Zwet WC, Kaiser AM, Van Elburg RM, et al. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates. J Hosp Infect 2005; 61:300-311.
6. Couto RC, Carvalho EAA, Pedrosa TMG, Pedroso ER, Neto MC, Biscione FM. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am J Infect Control 2007; 35:183-189.
7. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001; 29:152-157.
8. Su B, Hsieh H, Chiu H, Lin H, Lin H. Nosocomial infection in a neonatal intensive care unit: a prospective study in Taiwan. Am J Infect Control 2007; 35:190-195.
9. Powell PJ, Powell CV, Hollis S, Robinson MJ. When will my baby go home? Arch Dis Child 1992; 67:1214-1216.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC-definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
11. Haley R. Cost-benefit analysis of infection control programs. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston: Lippincott-Raven; 1992:249-267.
12. Maxwell M, Heaney D, Howie JG, Noble S. General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993; 307:1190-1194.
13. Amsden GW, Schentag JJ. Tables of antimicrobial agent pharmacology. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingston; 1995:492-528.
14. De Campos Bannwart D, Rebello C, Sadeck LS, Pontes MD, Araujo Ramos JL, Leone CR. Prediction of length of hospital stay in neonatal units for very low birth weight infants. J Perinatol 1999; 19:92-96.
15. Zernikow B, Holtmannspotter K, Michel E, Hornschuh F, Groote K, Hennecke KH. Predicting length of stay in preterm neonates. Eur J Pediatr 1999; 158:59-62.
16. Rogowski J. Measuring the cost of neonatal and perinatal care. Pediatrics 1999; 103:329-335.
17. Rosenthal VD, Guzman S, Migone O, Crnich J. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003; 31:475-480.
18. Higuera F, Rangel-Frausto MS, Rosenthal VD, et al. Attributable cost and length of hospital stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007; 28: 31-35.
19. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158:473-477.
20. Bregenzer T, Conen D, Sakmann P, Widmer A. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998; 158:151-156.
21. Doebbeling BN, Stanly GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327:88-93.